OMER Q4 2022 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$835M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0+100.0% YoY

Gross Profit

$0

Operating Income

-$40M

Net Income

$129M

EPS (Diluted)

$2.05

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$591M

Total Liabilities

$505M

Stockholders' Equity

$86M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	-$80M	+100.0%
Gross Profit	$0	-$79M	+100.0%
Operating Income	-$40M	-$101M	+60.2%
Net Income	$129M	$281M	-54.1%